Need Help?

Feasibility and safety of a multi-cancer blood test for screening and intervention

We evaluated the feasibility and safety of blood testing for cancer in an interventional study of 10,006 women. Positive tests for DNA or protein were independently confirmed and diagnostic PET-CT imaging was used to localize disease. During the study, 26 cancers were first detected by blood testing, 24 more by standard-of-care screening, and 46 by neither approach. Surgicalexcision of the primary tumors was performed on 12 cancers first detected by blood testing.1.0% of participants underwent PET-CT imaging based on false positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multi-cancer blood testing, when followed by PET-CT localization, can be safely incorporated into routineclinical care, in some cases leading to surgery with intent to cure. Further studies will be required to determine the clinical validity and utility of multi-cancer blood testing.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001008415 Illumina HiSeq 4000 Illumina MiSeq 4127
EGAD00001008591 Illumina HiSeq 4000 81
EGAD00001008597 Illumina HiSeq 4000 Illumina MiSeq 5111
EGAD00001015360 Illumina HiSeq 4000 Illumina MiSeq 1
EGAD00001015426 Illumina HiSeq 4000 Illumina MiSeq 1
EGAD00001015458 Illumina HiSeq 4000 1
EGAD50000000444 9911
Publications Citations
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.
Science 369: 2020 eabb9601
420